1. |
Thongprayoon C, Tantrachoti P, Phatharacharukul P, et al. Associated immunological disorders and cellular immune dysfunction in thymoma: a study of 87 cases from Thailand. Arch Immunol Ther Exp (Warsz), 2013, 61(1): 85-93.
|
2. |
Detterbeck FC, Parsons AM. Management of stage I and II thymoma. Thorac Surg Clin, 2011, 21(1): 59-67.
|
3. |
Bretti S, Berruti A, Loddo C, et al. Multimodal management of stages III-IVa malignant thymoma. Lung Cancer, 2004, 44(1): 69-77.
|
4. |
Fujii Y. Thymus, thymoma and myasthenia gravis. Surg Today, 2013, 43(5): 461-466.
|
5. |
Shelly S, Agmon-Levin N, Altman A, et al. Thymoma and autoimmunity. Cell Mol Immunol, 2011, 8(3): 199-202.
|
6. |
杨华夏, 郭静波, 梁乃新, 等. 系统性红斑狼疮合并胸腺瘤的临床特点分析.基础医学与临床, 2016, 36(2): 243-247.
|
7. |
Evoli A, Minicuci GM, Vitaliani R, et al. Paraneoplastic diseases associated with thymoma. J Neurol, 2007, 254(6): 756-762.
|
8. |
Gamanagatti S, Sharma R, Hatimota P, et al. Giant thymolipoma. Am J Roentgenol, 2005, 185(1): 283-284.
|
9. |
Krawczyk P, Adamczyk-Korbel M, Kieszko R, et al. Immunological system status and the appearance of respiratory system disturbances in thymectomized patients. Arch Immunol Ther Exp (Warsz), 2007, 55(1): 49-56.
|
10. |
周剑平, 项轶, 时国朝, 等. 胸腺瘤切除术后伴发空洞型肺结核 1 例并文献复习.中国感染与化疗杂志, 2015, (3): 271-274.
|
11. |
Horinouchi H, Asakura K, Kimura Y, et al. Prognosis of surgically treated thymic epithelial tumors. Nihon Geka Gakkai Zasshi, 2006, 107(6): 262-267.
|